Prognosis : Infectious Diseases

IMPORTANT: as of September 2016, all of the cases in this app are now available in the "Prognosis: Your Diagnosis" app.

If you own an iPhone 4s, iPad 2, or newer device, please download the "Prognosis: Your Diagnosis" app instead; it contains 1100+ case studies across 30+ specialties in English, French, Spanish, Italian, and Portuguese.

This app is temporarily being kept active for the benefit of users on older devices, but will be withdrawn in the coming months.

***********************************
Challenge your knowledge on the diagnosis and management of infectious disease. Refresh your memory about tropical diseases, travel medicine, and the pandemic influenzas that threaten the entire world.

Prognosis: Infectious Diseases is brought to you by the creators of Prognosis: Your Diagnosis the #1 free medical app. Explore 32 varied clinical cases based on actual patients and update your knowledge on the latest therapeutic guidelines.

Each clinical case can be navigated in a matter of minutes, while the comprehensive discussions serve as an valuable update for busy physicians, while being an educational tool for residents, medical students and other healthcare professionals studying for academic and licensure exams.

The diseases covered include:

1. Acute Epiglottitis
2. Anthrax, Cutaneous
3. Aspergilloma
4. Botulism
5. Brucellosis
6. Cryptosporidiosis
7. Cutaneous Leishmaniasis
8. Giardiasis
9. Hepatitis C with MPGN
10. HIV/AIDS
11. Infectious Mononucleosis
12. Infective Endocarditis
13. Legionnaires Disease
14. Leprosy
15. Leptospirosis
16. Lyme Disease
17. Malaria, Plasmodium Vivax
18. Meningitis, Bacterial
19. Neurocysticercosis
20. P. jiroveci pneumonia
21. Pertussis
22. Psittacosis
23. Rocky Mountain Spotted Fever
24. Schistosomiasis
25. Scrub Typhus
26. Septic Arthritis
27. Tinea Pedis
28. Toxoplasmosis
29. Tropical Pulmonary Eosinophilia
30. Tuberculosis, Breast
31. Tuberculosis, Miliary
32. West Nile Virus

For comments, criticisms or to share ideas on new cases, contact us at [email protected].